Şunu aradınız:: sugammadex (İngilizce - Maltaca)

re-administration of sugammadex:
l-għoti mill-ġdid ta’ sugammadex:

the active substance is sugammadex.
is-sustanza attiva hi sugammadex.

the relation to sugammadex is uncertain.
ir- relazzjoni ma ’ sugammadex hi inċerta.

bridion 100 mg/ml injection sugammadex
bridion 100 mg/ml injezzjoni sugammadex

bridion 100 mg/ ml injection sugammadex iv
bridion 100 mg/ ml injezzjoni sugammadex iv

bridion contains the active substance sugammadex.
bridion fih is-sustanza attiva sugammadex.

sugammadex can be used during breast-feeding.
sugammadex jista’ jintuża waqt it-treddigħ.

bridion 100 mg/ml solution for injection sugammadex
bridion 100 mg/ml soluzzjoni għall-injezzjoni sugammadex

for re-administration of sugammadex see section 4.2.
għall-għoti mill-ġdid ta’ sugammadex ara sezzjoni 4.2.

1 ml contains 100 mg sugammadex (as sodium salt).
1 ml fih 100 mg ta ’ sugammadex (bħala melħ tas- sodium).

2 ml contains sugammadex sodium equivalent to 200 mg sugammadex.
gĦamla kwalitattiva u kwantitattiva

1 ml contains 100 mg sugammadex (as sugammadex sodium).
1 ml fih 100 mg ta’ sugammadex (bħala sugammadex sodium).

animal studies have shown excretion of sugammadex in breast milk.
studji f’annimali wrew l-eliminazzjoni ta’ sugammadex fil-ħalib tas-sider tal-bniedem.

sugammadex should be administered intravenously as a single bolus injection.
sugammadex għandu jingħata ġol-vina bħala injezzjoni waħda bolus.

each vial of 2 ml contains sugammadex sodium equivalent to 200 mg sugammadex.
kull kunjett ta’ 2 ml fih sugammadex sodium ekwivalenti għal 200 mg ta’ sugammadex.

interactions potentially affecting the efficacy of sugammadex (displacement interactions):
interazzjonijiet li potenzjalment jistgħu jaffettwaw l-effikaċja ta’ sugammadex (interazzjonijiet ta’ spostament):

sugammadex should only be administered by, or under the supervision of an anaesthetist.
sugammadex għandu jingħata biss minn, jew taħt is-superviżjoni ta’ anestetista.

sugammadex is a modified gamma cyclodextrin which is a selective relaxant binding agent.
sugammadex hu gamma cyclodextrin modifikata li hi aġent selettiv rilassanti li jorbot.

interactions potentially affecting the efficacy of sugammadex (see also section 4.4):
interazzjonijiet li potenzjalment jistgħu jaffettwaw l- effikaċja ta ’ sugammadex (ara wkoll sezzjoni 4. 4):

in a human tolerance study sugammadex was administered in doses up to 96 mg/kg.
fi sudju dwar it-tolleranza fil-bniedem, sugammadex ingħata f’dożi sa 96 mg/kg.